These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 1730084

  • 1. A2 domain of human recombinant-derived factor VIII is required for procoagulant activity but not for thrombin cleavage.
    Pittman DD, Millenson M, Marquette K, Bauer K, Kaufman RJ.
    Blood; 1992 Jan 15; 79(2):389-97. PubMed ID: 1730084
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Mild hemophilia A caused by increased rate of factor VIII A2 subunit dissociation: evidence for nonproteolytic inactivation of factor VIIIa in vivo.
    Pipe SW, Eickhorst AN, McKinley SH, Saenko EL, Kaufman RJ.
    Blood; 1999 Jan 01; 93(1):176-83. PubMed ID: 9864159
    [Abstract] [Full Text] [Related]

  • 5. Structural basis for the decreased procoagulant activity of human factor VIII compared to the porcine homolog.
    Lollar P, Parker ET.
    J Biol Chem; 1991 Jul 05; 266(19):12481-6. PubMed ID: 1905722
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The factor V B-domain provides two functions to facilitate thrombin cleavage and release of the light chain.
    Marquette KA, Pittman DD, Kaufman RJ.
    Blood; 1995 Oct 15; 86(8):3026-34. PubMed ID: 7579396
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Factor VIII C2 domain contains the thrombin-binding site responsible for thrombin-catalyzed cleavage at Arg1689.
    Nogami K, Shima M, Hosokawa K, Nagata M, Koide T, Saenko EL, Tanaka I, Shibata M, Yoshioka A.
    J Biol Chem; 2000 Aug 18; 275(33):25774-80. PubMed ID: 10831589
    [Abstract] [Full Text] [Related]

  • 15. Identification of residues contributing to A2 domain-dependent structural stability in factor VIII and factor VIIIa.
    Wakabayashi H, Fay PJ.
    J Biol Chem; 2008 Apr 25; 283(17):11645-51. PubMed ID: 18299331
    [Abstract] [Full Text] [Related]

  • 16. Characterization of the interaction between the A2 subunit and A1/A3-C1-C2 dimer in human factor VIIIa.
    Fay PJ, Smudzin TM.
    J Biol Chem; 1992 Jul 05; 267(19):13246-50. PubMed ID: 1618828
    [Abstract] [Full Text] [Related]

  • 17. Cofactor activity in factor VIIIa of the blood clotting pathway is stabilized by an interdomain bond between His281 and Ser524 formed in factor VIII.
    Wakabayashi H, Monaghan M, Fay PJ.
    J Biol Chem; 2014 May 16; 289(20):14020-9. PubMed ID: 24692542
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Ca2+ binding to the first epidermal growth factor-like domain of human blood coagulation factor IX promotes enzyme activity and factor VIII light chain binding.
    Lenting PJ, Christophe OD, Maat H, Rees DJ, Mertens K.
    J Biol Chem; 1996 Oct 11; 271(41):25332-7. PubMed ID: 8810297
    [Abstract] [Full Text] [Related]

  • 20. Kinetics of factor VIII light-chain cleavage by thrombin and factor Xa. A regulatory role of the factor VIII heavy-chain region Lys713-Arg740.
    Donath MJ, Lenting PJ, Van Mourik JA, Mertens K.
    Eur J Biochem; 1996 Sep 01; 240(2):365-72. PubMed ID: 8841400
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.